Vinblastine, 5-azacytidine, and VP-16-213 therapy for previously treated patients with acute nonlymphocytic leukemia
- PMID: 72605
Vinblastine, 5-azacytidine, and VP-16-213 therapy for previously treated patients with acute nonlymphocytic leukemia
Similar articles
-
[Acute monocytic leukemia and acute myelomonocytic leukemia: treatment using VP 16213].Bull Cancer. 1974 Jul-Sep;61(3):419-26. Bull Cancer. 1974. PMID: 4533742 French. No abstract available.
-
Influence of a new relapse treatment for acute myeloid leukemia (AML) on in vitro granulopoiesis.Anticancer Res. 1983 Mar-Apr;3(2):127-31. Anticancer Res. 1983. PMID: 6573868
-
[Treatment of acute nonlymphocytic leukemia in children].Rinsho Ketsueki. 1982 Apr;23(4):476-83. Rinsho Ketsueki. 1982. PMID: 6957629 Japanese. No abstract available.
-
Etoposide: fifteen years experience.Bone Marrow Transplant. 1989 Jan;4 Suppl 1:52-5. Bone Marrow Transplant. 1989. PMID: 2653518 Review. No abstract available.
-
[Problems and perspectives of chemotherapy in leukemias].Recenti Prog Med. 1975 Oct;59(4):330-44. Recenti Prog Med. 1975. PMID: 769103 Review. Italian. No abstract available.
Cited by
-
High-dose melphalan and autologous bone marrow transplant for relapsed acute leukaemia.Cancer Chemother Pharmacol. 1983;10(2):109-11. doi: 10.1007/BF00446220. Cancer Chemother Pharmacol. 1983. PMID: 6339094
-
Etoposide and teniposide in the treatment of acute leukemia.Med Oncol Tumor Pharmacother. 1990;7(1):3-10. doi: 10.1007/BF03000484. Med Oncol Tumor Pharmacother. 1990. PMID: 2187120 Review.